{"url_path":"/sec/wgrx/8-k/2026-05-21/item-3-02","section_key":"item-3-02","section_title":"Item 3.02 Unregistered Sales of Equity Securities.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/2030763/0001493152-26-024723-index.html","accession_number":"0001493152-26-024723","cik":"0002030763","ticker":"WGRX","issuer_name":"Wellgistics Health, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2030763/0001493152-26-024723-index.html","primary_entity_key":"0002030763","primary_entity_name":"Wellgistics Health, Inc."},"word_count":113,"has_tables":true,"body_markdown":"**Item\n3.02 Unregistered Sales of Equity Securities.**\n\n** **\n\nThe\ninformation set forth in Item 1.01 of this Current Report on Form 8-K regarding the Amendment and the Amended Note is incorporated herein\nby reference.\n\n \n\nThe\nAmended Note was issued in a private placement exempt from registration under the Securities Act of 1933, as amended (the “Securities\nAct”), pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder. The Investor represented\nthat it acquired the Amended Note for investment purposes and not with a view to distribution, and the Amended Note and any securities\nissuable thereunder have not been registered under the Securities Act or applicable state securities laws."}